PECULIARITIES OF COVID-19 SUSCEPTIBILITY IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinological disease among women of reproductive age, the prevalence of which reaches up to 15% in the world depending on the study population and the diagnostic criteria used. Purpose: analysis of existing medical research on the increased susceptibility to Covid-19, its form and features among women with PCOS, coverage of research on this topic to raise awareness of Ukrainian physicians in building proper prevention, modernizing approaches to diagnosis, treatment and avoidance of Covid-19 complications in women with PCOS and to disseminate material and further in form PCOS patients about possible risks of Covid-19. Results and discussion. Women with PCOS are characterized by a higher incidence of cardiovascular disease, kidney damade, non-fatty steatohepatitis, achieving a body mass index over 30 kg/m2 , diabetes and endometrial mucosal cancer. Metabolic syndrome characterized by hypertension, obesity, insulin resistance and dyslipidemia is found in 22.7% of women with PCOS. Given the high prevalence of various risk factors for PCOS, which coincide with the severity of Covid-19, it can be argued that women with PCOS are a critical group of patients with a potentially higher risk of adverse effects of Covid-19. Conclusions. Despite their young age and gender, women with PCOS are at increased risk for Covid-19. Women with cardiovascular and metabolic diseases in PCOS are a group of patients with a potentially higher risk of complications from Covid-19. Women with PCOS should first be informed about the need for vaccination and preventive measures during the Covid-19 pandemic, monitoring the treatment of existing pathologies and prompt medical attention for SARS-CoV-2 infection.